"High-dose lanreotide in patients with acromegaly"

Registry ID

EUCTR2012-005313-39

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

AZIENDA OSPEDALIERA Spedali Civili di Brescia

Start date

2013-05-17

Completion date

2016-03-09

Last update

2026-08-16

Conditions

• acromegaly

Summary

confirm efficacy and safety of treatment with lanreoride at doses increased and reduced time intervals between doses in patients with acromegaly poorly responsive to standard treatment

Locations

• , , Italy

View on source registry